nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—ACHE—Physostigmine—glaucoma	0.0965	0.112	CbGbCtD
Dipivefrin—ACHE—Echothiophate—glaucoma	0.0965	0.112	CbGbCtD
Dipivefrin—BCHE—Physostigmine—glaucoma	0.0581	0.0672	CbGbCtD
Dipivefrin—BCHE—Echothiophate—glaucoma	0.0581	0.0672	CbGbCtD
Dipivefrin—ADRB2—Levobunolol—glaucoma	0.0554	0.0641	CbGbCtD
Dipivefrin—ADRB2—Metipranolol—glaucoma	0.0554	0.0641	CbGbCtD
Dipivefrin—ADRA2C—Apraclonidine—glaucoma	0.048	0.0555	CbGbCtD
Dipivefrin—ADRA2C—Brimonidine—glaucoma	0.048	0.0555	CbGbCtD
Dipivefrin—ADRB2—Carteolol—glaucoma	0.0471	0.0545	CbGbCtD
Dipivefrin—ADRA2B—Apraclonidine—glaucoma	0.0455	0.0527	CbGbCtD
Dipivefrin—ADRA2B—Brimonidine—glaucoma	0.0455	0.0527	CbGbCtD
Dipivefrin—ADRB2—Betaxolol—glaucoma	0.0318	0.0368	CbGbCtD
Dipivefrin—ADRA2A—Brimonidine—glaucoma	0.0317	0.0366	CbGbCtD
Dipivefrin—ADRA2A—Apraclonidine—glaucoma	0.0317	0.0366	CbGbCtD
Dipivefrin—ADRA1A—Apraclonidine—glaucoma	0.0304	0.0351	CbGbCtD
Dipivefrin—ADRB2—Timolol—glaucoma	0.0205	0.0237	CbGbCtD
Dipivefrin—Follicular conjunctivitis—Brimonidine—glaucoma	0.0204	0.166	CcSEcCtD
Dipivefrin—ADRA2C—Clonidine—glaucoma	0.0199	0.023	CbGbCtD
Dipivefrin—Follicular conjunctivitis—Dorzolamide—glaucoma	0.0195	0.159	CcSEcCtD
Dipivefrin—ADRA2B—Clonidine—glaucoma	0.0189	0.0219	CbGbCtD
Dipivefrin—ADRA2A—Clonidine—glaucoma	0.0131	0.0152	CbGbCtD
Dipivefrin—ADRA1A—Clonidine—glaucoma	0.0126	0.0146	CbGbCtD
Dipivefrin—Stinging—Echothiophate—glaucoma	0.00634	0.0518	CcSEcCtD
Dipivefrin—Stinging—Carbachol—glaucoma	0.00378	0.0309	CcSEcCtD
Dipivefrin—Stinging—Levobunolol—glaucoma	0.00372	0.0304	CcSEcCtD
Dipivefrin—Stinging—Latanoprost—glaucoma	0.00345	0.0282	CcSEcCtD
Dipivefrin—Mydriasis—Apraclonidine—glaucoma	0.0028	0.0229	CcSEcCtD
Dipivefrin—Stinging—Bimatoprost—glaucoma	0.00268	0.0219	CcSEcCtD
Dipivefrin—Stinging—Brimonidine—glaucoma	0.00237	0.0194	CcSEcCtD
Dipivefrin—Mydriasis—Travoprost—glaucoma	0.00229	0.0187	CcSEcCtD
Dipivefrin—Stinging—Dorzolamide—glaucoma	0.00226	0.0185	CcSEcCtD
Dipivefrin—Stinging—Pilocarpine—glaucoma	0.00214	0.0175	CcSEcCtD
Dipivefrin—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00212	1	CbGdCrCtD
Dipivefrin—Conjunctivitis—Metipranolol—glaucoma	0.00187	0.0153	CcSEcCtD
Dipivefrin—Conjunctivitis—Carteolol—glaucoma	0.00174	0.0142	CcSEcCtD
Dipivefrin—Conjunctivitis—Levobunolol—glaucoma	0.00164	0.0134	CcSEcCtD
Dipivefrin—Pain—Echothiophate—glaucoma	0.00157	0.0128	CcSEcCtD
Dipivefrin—Conjunctivitis—Latanoprost—glaucoma	0.00152	0.0124	CcSEcCtD
Dipivefrin—Arrhythmia—Carteolol—glaucoma	0.00143	0.0117	CcSEcCtD
Dipivefrin—Arrhythmia—Carbachol—glaucoma	0.00137	0.0112	CcSEcCtD
Dipivefrin—Arrhythmia—Levobunolol—glaucoma	0.00135	0.0111	CcSEcCtD
Dipivefrin—Hypertension—Metipranolol—glaucoma	0.0013	0.0106	CcSEcCtD
Dipivefrin—Conjunctivitis—Apraclonidine—glaucoma	0.00122	0.00994	CcSEcCtD
Dipivefrin—Stinging—Timolol—glaucoma	0.00121	0.00992	CcSEcCtD
Dipivefrin—Conjunctivitis—Brimonidine—glaucoma	0.00104	0.00853	CcSEcCtD
Dipivefrin—Arrhythmia—Apraclonidine—glaucoma	0.001	0.0082	CcSEcCtD
Dipivefrin—Conjunctivitis—Dorzolamide—glaucoma	0.000997	0.00815	CcSEcCtD
Dipivefrin—Conjunctivitis—Travoprost—glaucoma	0.000993	0.00811	CcSEcCtD
Dipivefrin—Conjunctivitis—Brinzolamide—glaucoma	0.00098	0.00801	CcSEcCtD
Dipivefrin—Conjunctivitis—Pilocarpine—glaucoma	0.000942	0.0077	CcSEcCtD
Dipivefrin—Pain—Carbachol—glaucoma	0.000935	0.00764	CcSEcCtD
Dipivefrin—Pain—Levobunolol—glaucoma	0.00092	0.00752	CcSEcCtD
Dipivefrin—Hypersensitivity—Metipranolol—glaucoma	0.000906	0.0074	CcSEcCtD
Dipivefrin—Arrhythmia—Brimonidine—glaucoma	0.000861	0.00704	CcSEcCtD
Dipivefrin—Pain—Latanoprost—glaucoma	0.000854	0.00697	CcSEcCtD
Dipivefrin—Hypersensitivity—Carteolol—glaucoma	0.000839	0.00686	CcSEcCtD
Dipivefrin—Arrhythmia—Dorzolamide—glaucoma	0.000823	0.00672	CcSEcCtD
Dipivefrin—Hypertension—Bimatoprost—glaucoma	0.000818	0.00669	CcSEcCtD
Dipivefrin—Arrhythmia—Brinzolamide—glaucoma	0.000809	0.00661	CcSEcCtD
Dipivefrin—Hypersensitivity—Levobunolol—glaucoma	0.000793	0.00648	CcSEcCtD
Dipivefrin—Arrhythmia—Pilocarpine—glaucoma	0.000777	0.00635	CcSEcCtD
Dipivefrin—Hypertension—Brimonidine—glaucoma	0.000725	0.00592	CcSEcCtD
Dipivefrin—Hypertension—Dorzolamide—glaucoma	0.000692	0.00565	CcSEcCtD
Dipivefrin—Hypertension—Travoprost—glaucoma	0.000689	0.00563	CcSEcCtD
Dipivefrin—Pain—Apraclonidine—glaucoma	0.000682	0.00558	CcSEcCtD
Dipivefrin—Hypertension—Brinzolamide—glaucoma	0.00068	0.00556	CcSEcCtD
Dipivefrin—Tachycardia—Brimonidine—glaucoma	0.000669	0.00546	CcSEcCtD
Dipivefrin—Pain—Bimatoprost—glaucoma	0.000662	0.00541	CcSEcCtD
Dipivefrin—Conjunctivitis—Betaxolol—glaucoma	0.000655	0.00535	CcSEcCtD
Dipivefrin—Hypertension—Pilocarpine—glaucoma	0.000654	0.00534	CcSEcCtD
Dipivefrin—Tachycardia—Travoprost—glaucoma	0.000636	0.00519	CcSEcCtD
Dipivefrin—Tachycardia—Brinzolamide—glaucoma	0.000628	0.00513	CcSEcCtD
Dipivefrin—Arrhythmia—Clonidine—glaucoma	0.000621	0.00507	CcSEcCtD
Dipivefrin—Tachycardia—Pilocarpine—glaucoma	0.000603	0.00493	CcSEcCtD
Dipivefrin—Hypersensitivity—Apraclonidine—glaucoma	0.000588	0.0048	CcSEcCtD
Dipivefrin—Pain—Brimonidine—glaucoma	0.000586	0.00479	CcSEcCtD
Dipivefrin—Pain—Dorzolamide—glaucoma	0.000559	0.00457	CcSEcCtD
Dipivefrin—Pain—Travoprost—glaucoma	0.000557	0.00455	CcSEcCtD
Dipivefrin—Pain—Brinzolamide—glaucoma	0.00055	0.00449	CcSEcCtD
Dipivefrin—Arrhythmia—Betaxolol—glaucoma	0.00054	0.00442	CcSEcCtD
Dipivefrin—Conjunctivitis—Timolol—glaucoma	0.000535	0.00437	CcSEcCtD
Dipivefrin—Pain—Pilocarpine—glaucoma	0.000529	0.00432	CcSEcCtD
Dipivefrin—Hypersensitivity—Brimonidine—glaucoma	0.000505	0.00412	CcSEcCtD
Dipivefrin—Hypersensitivity—Dorzolamide—glaucoma	0.000482	0.00394	CcSEcCtD
Dipivefrin—Tachycardia—Clonidine—glaucoma	0.000482	0.00394	CcSEcCtD
Dipivefrin—Hypersensitivity—Travoprost—glaucoma	0.00048	0.00392	CcSEcCtD
Dipivefrin—Hypersensitivity—Brinzolamide—glaucoma	0.000474	0.00387	CcSEcCtD
Dipivefrin—Hypersensitivity—Pilocarpine—glaucoma	0.000455	0.00372	CcSEcCtD
Dipivefrin—Arrhythmia—Timolol—glaucoma	0.000441	0.00361	CcSEcCtD
Dipivefrin—Pain—Clonidine—glaucoma	0.000422	0.00345	CcSEcCtD
Dipivefrin—Tachycardia—Betaxolol—glaucoma	0.000419	0.00343	CcSEcCtD
Dipivefrin—Hypertension—Timolol—glaucoma	0.000371	0.00303	CcSEcCtD
Dipivefrin—Pain—Betaxolol—glaucoma	0.000368	0.003	CcSEcCtD
Dipivefrin—Hypersensitivity—Clonidine—glaucoma	0.000364	0.00297	CcSEcCtD
Dipivefrin—Hypersensitivity—Betaxolol—glaucoma	0.000317	0.00259	CcSEcCtD
Dipivefrin—Pain—Timolol—glaucoma	0.0003	0.00245	CcSEcCtD
Dipivefrin—Epinephrine—TNF—glaucoma	0.000292	1	CrCbGaD
Dipivefrin—Hypersensitivity—Timolol—glaucoma	0.000259	0.00211	CcSEcCtD
Dipivefrin—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	1.93e-05	0.00185	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—SMO—glaucoma	1.89e-05	0.00182	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.89e-05	0.00181	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.86e-05	0.00179	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—PAX6—glaucoma	1.84e-05	0.00176	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—LRP12—glaucoma	1.82e-05	0.00175	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CA2—glaucoma	1.82e-05	0.00175	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—C3—glaucoma	1.8e-05	0.00173	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.78e-05	0.00171	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.78e-05	0.00171	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.76e-05	0.00169	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.76e-05	0.00169	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CA1—glaucoma	1.73e-05	0.00166	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.7e-05	0.00163	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CTSA—glaucoma	1.68e-05	0.00161	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—OPN4—glaucoma	1.67e-05	0.0016	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	1.66e-05	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—EDN1—glaucoma	1.65e-05	0.00158	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—OPN4—glaucoma	1.65e-05	0.00158	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.64e-05	0.00157	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—EDN1—glaucoma	1.62e-05	0.00156	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TGFB2—glaucoma	1.62e-05	0.00156	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—SOD1—glaucoma	1.62e-05	0.00155	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CA2—glaucoma	1.58e-05	0.00152	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—OPN4—glaucoma	1.56e-05	0.00149	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HEYL—glaucoma	1.55e-05	0.00149	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.54e-05	0.00148	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—EDN1—glaucoma	1.54e-05	0.00147	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HEYL—glaucoma	1.53e-05	0.00147	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—SOD1—glaucoma	1.51e-05	0.00145	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PTGFR—glaucoma	1.5e-05	0.00144	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PTGFR—glaucoma	1.48e-05	0.00142	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.45e-05	0.00139	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HEYL—glaucoma	1.45e-05	0.00139	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—TXN—glaucoma	1.44e-05	0.00138	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—C3—glaucoma	1.44e-05	0.00138	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.43e-05	0.00137	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—C3—glaucoma	1.42e-05	0.00136	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CA1—glaucoma	1.41e-05	0.00135	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PTGFR—glaucoma	1.4e-05	0.00134	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CTSA—glaucoma	1.36e-05	0.00131	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—OPN4—glaucoma	1.36e-05	0.0013	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—EDN1—glaucoma	1.34e-05	0.00129	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—C3—glaucoma	1.34e-05	0.00129	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.31e-05	0.00126	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.3e-05	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CA2—glaucoma	1.29e-05	0.00123	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—TXN—glaucoma	1.28e-05	0.00123	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.28e-05	0.00123	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—SMO—glaucoma	1.28e-05	0.00123	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HEYL—glaucoma	1.27e-05	0.00121	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—SMO—glaucoma	1.26e-05	0.00121	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—OPN4—glaucoma	1.26e-05	0.00121	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.25e-05	0.0012	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—EDN1—glaucoma	1.25e-05	0.0012	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—MMP1—glaucoma	1.24e-05	0.00119	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—SOD1—glaucoma	1.23e-05	0.00118	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PTGFR—glaucoma	1.23e-05	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—SMO—glaucoma	1.2e-05	0.00115	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—CAV1—glaucoma	1.19e-05	0.00114	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HEYL—glaucoma	1.18e-05	0.00113	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—RPTOR—glaucoma	1.17e-05	0.00113	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—C3—glaucoma	1.17e-05	0.00113	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—MMP1—glaucoma	1.17e-05	0.00112	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.17e-05	0.00112	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.17e-05	0.00112	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.16e-05	0.00111	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—RPTOR—glaucoma	1.16e-05	0.00111	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—MMP1—glaucoma	1.16e-05	0.00111	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PTGFR—glaucoma	1.14e-05	0.00109	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NCK2—glaucoma	1.14e-05	0.00109	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—FN1—glaucoma	1.13e-05	0.00108	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NCK2—glaucoma	1.12e-05	0.00108	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GSTT1—glaucoma	1.12e-05	0.00107	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TXN—glaucoma	1.12e-05	0.00107	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—CAV1—glaucoma	1.11e-05	0.00106	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—RPTOR—glaucoma	1.1e-05	0.00105	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—C3—glaucoma	1.09e-05	0.00105	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NCK2—glaucoma	1.06e-05	0.00102	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—FN1—glaucoma	1.05e-05	0.00101	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—MMP1—glaucoma	1.05e-05	0.001	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—SMO—glaucoma	1.05e-05	0.001	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GSTT1—glaucoma	9.96e-06	0.000954	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—SMO—glaucoma	9.72e-06	0.000932	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HDAC9—glaucoma	9.67e-06	0.000927	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—RPTOR—glaucoma	9.59e-06	0.000919	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HDAC9—glaucoma	9.55e-06	0.000915	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	9.51e-06	0.000911	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—MMP1—glaucoma	9.38e-06	0.0009	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—EDN1—glaucoma	9.3e-06	0.000891	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NCK2—glaucoma	9.29e-06	0.00089	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—EDN1—glaucoma	9.18e-06	0.00088	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—MMP2—glaucoma	9.07e-06	0.00087	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TXN—glaucoma	9.06e-06	0.000868	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HDAC9—glaucoma	9.03e-06	0.000866	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9e-06	0.000863	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—CAV1—glaucoma	9e-06	0.000862	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—NOS3—glaucoma	8.97e-06	0.000859	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—RPTOR—glaucoma	8.91e-06	0.000854	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ABCA1—glaucoma	8.89e-06	0.000852	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CYP1B1—glaucoma	8.89e-06	0.000852	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—EDN1—glaucoma	8.69e-06	0.000833	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GSTT1—glaucoma	8.65e-06	0.000829	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NCK2—glaucoma	8.63e-06	0.000827	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—FN1—glaucoma	8.56e-06	0.000821	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—EDN1—glaucoma	8.45e-06	0.00081	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—NOS3—glaucoma	8.38e-06	0.000803	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—EDN1—glaucoma	8.34e-06	0.000799	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—C3—glaucoma	8.12e-06	0.000779	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—MMP2—glaucoma	8.1e-06	0.000776	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.03e-06	0.00077	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—C3—glaucoma	8.02e-06	0.000769	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ABCA1—glaucoma	7.93e-06	0.00076	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CYP1B1—glaucoma	7.93e-06	0.00076	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HDAC9—glaucoma	7.9e-06	0.000757	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—EDN1—glaucoma	7.89e-06	0.000756	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	7.59e-06	0.000728	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—C3—glaucoma	7.59e-06	0.000727	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SMO—glaucoma	7.57e-06	0.000725	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SMO—glaucoma	7.47e-06	0.000716	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—C3—glaucoma	7.38e-06	0.000707	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HDAC9—glaucoma	7.34e-06	0.000703	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—C3—glaucoma	7.28e-06	0.000698	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—GSTM1—glaucoma	7.11e-06	0.000681	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SMO—glaucoma	7.07e-06	0.000678	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	7.06e-06	0.000676	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSTT1—glaucoma	7.02e-06	0.000673	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NTRK2—glaucoma	6.92e-06	0.000663	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—EDN1—glaucoma	6.9e-06	0.000661	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—C3—glaucoma	6.89e-06	0.000661	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CYP1B1—glaucoma	6.89e-06	0.000661	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ABCA1—glaucoma	6.89e-06	0.000661	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NTRK2—glaucoma	6.83e-06	0.000655	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—NOS3—glaucoma	6.8e-06	0.000652	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—C3—glaucoma	6.63e-06	0.000636	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NTRK2—glaucoma	6.46e-06	0.00062	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—VEGFA—glaucoma	6.46e-06	0.000619	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—EDN1—glaucoma	6.41e-06	0.000614	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—GSTM1—glaucoma	6.34e-06	0.000608	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—MTHFR—glaucoma	6.28e-06	0.000602	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SMO—glaucoma	6.18e-06	0.000592	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—C3—glaucoma	6.16e-06	0.000591	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—VEGFA—glaucoma	6.03e-06	0.000578	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—C3—glaucoma	6.02e-06	0.000577	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NGFR—glaucoma	5.94e-06	0.000569	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NGFR—glaucoma	5.86e-06	0.000562	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—APOE—glaucoma	5.85e-06	0.000561	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—CAV1—glaucoma	5.79e-06	0.000555	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SMO—glaucoma	5.74e-06	0.00055	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NTRK2—glaucoma	5.65e-06	0.000542	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NTRK1—glaucoma	5.64e-06	0.000541	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—MTHFR—glaucoma	5.6e-06	0.000537	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—C3—glaucoma	5.6e-06	0.000537	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CYP1B1—glaucoma	5.6e-06	0.000537	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ABCA1—glaucoma	5.6e-06	0.000537	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NTRK1—glaucoma	5.57e-06	0.000534	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NGFR—glaucoma	5.55e-06	0.000532	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—GSTM1—glaucoma	5.51e-06	0.000528	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NTRK1—glaucoma	5.27e-06	0.000505	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NTRK2—glaucoma	5.25e-06	0.000503	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—APOE—glaucoma	5.22e-06	0.0005	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	5.2e-06	0.000498	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—CAV1—glaucoma	5.17e-06	0.000496	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDKN2B—glaucoma	5.13e-06	0.000492	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EDN1—glaucoma	4.99e-06	0.000478	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EDN1—glaucoma	4.93e-06	0.000472	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VEGFA—glaucoma	4.9e-06	0.00047	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—TP53—glaucoma	4.88e-06	0.000468	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—MTHFR—glaucoma	4.87e-06	0.000467	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	4.86e-06	0.000466	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NGFR—glaucoma	4.85e-06	0.000465	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EDN1—glaucoma	4.66e-06	0.000447	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NTRK1—glaucoma	4.61e-06	0.000442	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NGF—glaucoma	4.58e-06	0.000439	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—TP53—glaucoma	4.56e-06	0.000437	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—APOE—glaucoma	4.53e-06	0.000434	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NGF—glaucoma	4.53e-06	0.000434	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NGFR—glaucoma	4.51e-06	0.000432	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—CAV1—glaucoma	4.49e-06	0.00043	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—GSTM1—glaucoma	4.47e-06	0.000429	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—NOS3—glaucoma	4.38e-06	0.00042	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—C3—glaucoma	4.36e-06	0.000418	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—C3—glaucoma	4.3e-06	0.000412	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NGF—glaucoma	4.28e-06	0.00041	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NTRK1—glaucoma	4.28e-06	0.00041	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	4.25e-06	0.000407	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EDN1—glaucoma	4.07e-06	0.000391	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—C3—glaucoma	4.07e-06	0.00039	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APOE—glaucoma	4.06e-06	0.000389	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CAV1—glaucoma	4.02e-06	0.000385	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTGS2—glaucoma	4.01e-06	0.000384	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APOE—glaucoma	4.01e-06	0.000384	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CAV1—glaucoma	3.97e-06	0.00038	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—MTHFR—glaucoma	3.95e-06	0.000379	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	3.94e-06	0.000378	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—NOS3—glaucoma	3.91e-06	0.000375	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—FN1—glaucoma	3.83e-06	0.000367	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APOE—glaucoma	3.79e-06	0.000363	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EDN1—glaucoma	3.79e-06	0.000363	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—BAD—glaucoma	3.78e-06	0.000362	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—FN1—glaucoma	3.78e-06	0.000362	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CAV1—glaucoma	3.76e-06	0.00036	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NGF—glaucoma	3.74e-06	0.000359	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—BAD—glaucoma	3.73e-06	0.000358	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TP53—glaucoma	3.7e-06	0.000355	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—APOE—glaucoma	3.68e-06	0.000353	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CAV1—glaucoma	3.65e-06	0.00035	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTGS2—glaucoma	3.58e-06	0.000343	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—FN1—glaucoma	3.57e-06	0.000343	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—C3—glaucoma	3.56e-06	0.000341	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—BAD—glaucoma	3.53e-06	0.000339	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NGF—glaucoma	3.48e-06	0.000333	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—NOS3—glaucoma	3.4e-06	0.000325	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APOE—glaucoma	3.31e-06	0.000318	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—C3—glaucoma	3.31e-06	0.000317	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CAV1—glaucoma	3.28e-06	0.000315	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—FN1—glaucoma	3.12e-06	0.0003	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTGS2—glaucoma	3.11e-06	0.000298	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—BAD—glaucoma	3.09e-06	0.000296	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APOE—glaucoma	3.08e-06	0.000295	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CAV1—glaucoma	3.05e-06	0.000292	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NOS3—glaucoma	3.04e-06	0.000291	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NOS3—glaucoma	3e-06	0.000288	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—FN1—glaucoma	2.9e-06	0.000278	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—BAD—glaucoma	2.87e-06	0.000275	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NOS3—glaucoma	2.84e-06	0.000272	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—NOS3—glaucoma	2.76e-06	0.000264	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	2.63e-06	0.000252	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDKN1B—glaucoma	2.6e-06	0.000249	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTGS2—glaucoma	2.52e-06	0.000242	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NOS3—glaucoma	2.48e-06	0.000238	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	2.46e-06	0.000236	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—glaucoma	2.44e-06	0.000234	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—glaucoma	2.41e-06	0.000231	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NOS3—glaucoma	2.31e-06	0.000221	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—glaucoma	2.28e-06	0.000218	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—glaucoma	2.19e-06	0.00021	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—glaucoma	2.16e-06	0.000207	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.15e-06	0.000206	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—glaucoma	2.05e-06	0.000196	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2e-06	0.000192	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—glaucoma	1.99e-06	0.000191	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—glaucoma	1.85e-06	0.000177	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—glaucoma	1.79e-06	0.000171	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.66e-06	0.000159	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TP53—glaucoma	1.65e-06	0.000159	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TP53—glaucoma	1.63e-06	0.000157	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TP53—glaucoma	1.55e-06	0.000148	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TP53—glaucoma	1.35e-06	0.00013	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TP53—glaucoma	1.26e-06	0.00012	CbGpPWpGaD
